Literature DB >> 28150860

Interleukin-10 family cytokines pathway: genetic variants and psoriasis.

E Galimova1,2, R Rätsep1, T Traks3, K Kingo3, V Escott-Price4, S Kõks1,5.   

Abstract

BACKGROUND: Interleukin (IL)-10 family cytokines IL-10, IL-19, IL-20 and IL-24 have been implicated in autoimmune diseases and we have previously reported that genetic variants in the IL10 gene cluster were associated with psoriasis.
OBJECTIVES: To analyse the relationship between genetic polymorphisms in the IL10 gene cluster and psoriasis. This study also explores whether there are gene-gene interactions among these genetic polymorphisms.
METHODS: A total of 377 patients with psoriasis and 403 matched healthy controls were enrolled to carry out a case-control study for 48 single-nucleotide polymorphisms (SNPs) of the IL10 gene cluster. Genotyping for the SNPs was conducted on the Applied Biosystems 3730 DNA Analyzer using SNPlex® technology. Generalized multifactor dimensionality reduction (GMDR) analysis was applied to discover a likely gene-gene interaction model among the SNPs.
RESULTS: The results showed that the allele distributions of IL10 gene cluster SNPs are significantly different between the case and control groups. Carriers of the IL10 T allele (rs1554286) and the IL20 T allele (rs1400986) conferred protection from psoriasis [odds ratio (OR) = 0·63, corrected P-value (Pc) = 0·007; OR = 0·62, Pc = 0·038, respectively]. GMDR analysis displayed a significant gene-gene interaction between IL10 (rs1554286) and IL20 (rs1518108) variants. The strongest protective effect was found with the block 1 haplotype ACATA in the IL10 gene (Pc = 0·004).
CONCLUSIONS: This study presents a novel finding that the combination of the two SNPs, IL10 (rs1554286) and IL20 (rs1518108), is associated with a reduced risk of psoriasis. Our results indicate that genetic variants of the immunomodulatory IL10 and IL20 genes may offer a protective effect in Europeans from Russia. Independent studies are required to verify the results and find a possible functional explanation.
© 2017 British Association of Dermatologists.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28150860     DOI: 10.1111/bjd.15363

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  6 in total

1.  Variants in PRKCE and KLC1, Potential Regulators of Type I Psoriasis.

Authors:  Jianxiao Xing; Ying Wang; Xincheng Zhao; Junqin Li; Ruixia Hou; Xuping Niu; Guohua Yin; Xinhua Li; Kaiming Zhang
Journal:  Clin Cosmet Investig Dermatol       Date:  2022-07-01

Review 2.  Psoriasis: An Immunogenetic Perspective.

Authors:  Ayca Kocaaga; Mustafa Kocaaga
Journal:  Glob Med Genet       Date:  2022-06-13

3.  The clinical significance of Mda-7/IL-24 and C-myb expression in tumor tissues of patients with diffuse large B cell lymphoma.

Authors:  Ming Ma; Riyang Zhao; Xingxiao Yang; Lianmei Zhao; Lihua Liu; Cong Zhang; Xuexiao Wang; Baoen Shan
Journal:  Exp Ther Med       Date:  2018-05-29       Impact factor: 2.447

4.  Combination of FLG mutations and SNPs of IL-17A and IL-19 influence on atopic dermatitis occurrence.

Authors:  Jolanta Klonowska; Jolanta Gleń; Roman J Nowicki; Magdalena Trzeciak
Journal:  Postepy Dermatol Alergol       Date:  2021-04-16       Impact factor: 1.837

5.  Common Variants in IL-20 Gene are Associated with Subclinical Atherosclerosis, Cardiovascular Risk Factors and IL-20 Levels in the Cohort of the Genetics of Atherosclerotic Disease (GEA) Mexican Study.

Authors:  Javier Angeles-Martínez; Rosalinda Posadas-Sánchez; Eyerahi Bravo-Flores; María Del Carmen González-Salazar; Gilberto Vargas-Alarcón
Journal:  Biomolecules       Date:  2020-01-03

6.  I-Kappa-B-Zeta Regulates Interleukin-17A/Tumor Necrosis Factor-Alpha Mediated Synergistic Induction of Interleukin-19 and Interleukin-20 in Humane Keratinocytes.

Authors:  Trine Bertelsen; Lars Iversen; Claus Johansen
Journal:  Ann Dermatol       Date:  2021-03-08       Impact factor: 1.444

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.